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Background: Inherited mutations in the LRRK2 protein are the common 
causes of Parkinson’s, but the mechanisms by which increased kinase activity 
of mutant LRRK2 leads to pathological events remain to be determined. In 
vitro assays (heterologous cell culture, phospho-protein mass spectrometry) 
suggest that several Rab proteins might be directly phosphorylated by 
LRRK2-G2019S. An in vivo screen of Rab expression in dopaminergic neurons 
in young adult Drosophila demonstrated a strong genetic interaction between 
LRRK2-G2019S and Rab10.  
Objective: To determine if Rab10 is necessary for LRRK2-induced 
pathophysiological responses in the neurons that control movement, vision, 
circadian activity and memory. These four systems were chosen because they 
are modulated by dopaminergic neurons in both humans and flies.    
Methods: LRRK2-G2019S was expressed in Drosophila dopaminergic neurons 
and the effects of Rab10 depletion on Proboscis Extension, retinal 
neurophysiology, circadian activity pattern (‘sleep’) and courtship memory 
determined in aged flies.      
Results: Rab10 loss-of-function rescued LRRK2-G2019S induced bradykinesia 
and retinal signalling deficits. Rab10 knock-down however, did not rescue the 
marked sleep phenotype which results from dopaminergic LRRK2-G2019S. 
Courtship memory is not affected by LRRK2, but is markedly improved by 
Rab10 depletion.  Anatomically, both LRRK2-G2019S and Rab10 are seen in 
the cytoplasm and at the synaptic endings of dopaminergic neurons.  
Conclusions: We conclude that, in Drosophila dopaminergic neurons, Rab10 
is involved in some, but not all, LRRK2-induced behavioral deficits. 
Therefore, variations in Rab expression may contribute to susceptibility of 







Mutations in the LRRK2 gene are the most frequent genetic cause of late onset 
Parkinson’s. The G2019S mutation increases LRRK2 kinase activity [1], 
leading to a toxic cascade that kills dopaminergic neurons in the substantia 
nigra. This results in bradykinesia and sleep disturbances, while loss of 
dopaminergic amacrine cells in the retina contributes to visual deficits. 
However, the main steps between LRRK2 and these pathological outcomes 
remain to be determined. One of the first steps that has been suggested is that 
LRRK2-G2019S may phosphorylate a  number of small GTPases (Rabs 
3,5,8,10,29,35 & 43) [2].  Cell culture experiments have shown a particular 
effect on Rab10 [2–7], (see [8] for review), while a visual screen of Drosophila 
synaptic processing indicated a particular synergy between Rab10 and 
G2019S [9]. As a molecular switch, phosphorylation of a Rab protein could 
result in changed effector binding with a series of downstream consequences. 
However, the level of Rab10 is quite disparate, even among different types of 
dopaminergic neurons [9,10] so that LRRK2 might not work in the same way 
in all dopaminergic neurons.      
Since most genetic mouse models of Parkinson’s have very weak phenotypes, 
with lack of neuropathology [11], we turned to the fly where manipulation of 
Parkinson’s disease related genes leads to marked phenotypes: bradykinesia 
[12], loss of dopaminergic neurons [13], tremor [14], retinal degeneration [15] 
and sleep disorder [16] (see, for review [17]). Parkinson’s-linked  genes shown 
to have powerful effects in the fly include not just LRRK2, but also α-synuclein 
[12], parkin and PINK1 [18,19] and DJ1 [20]. The advanced genetics, short 
lifespan, and high fecundity have allowed the identification of genes that are 
in the same pathway and thus show epistasis  (e.g. parkin and PINK1 [18,19]).  
To determine how important Rab10 is in the pathological cascade initiated by 
LRRK2 activity, we now deploy fly genetics test the knock-down/knock-out 
of Rab10 in dopaminergic neurons in the intact organism. Flies use 
dopaminergic neurons in four physiologically measurable systems: 
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movement, vision, sleep and memory. We find the movement and visual 
deficits seen in flies expressing LRRK2-G2019S in dopaminergic neurons are 
rescued by the depletion of Rab10. However, the marked sleep phenotype 
caused by dopaminergic expression of LRRK2-G2019S is not affected by 
manipulation of Rab10.  Conditioned courtship memory is not affected by 
LRRK2, though dopaminergic Rab10 reduction markedly improves this.  We 
therefore find a role for Rab10 downstream of activated LRRK2 in some, but 
not all, dopaminergic neurons in the activation of LRRK2-associated 
physiological deficits in Drosophila.   
Materials and Methods 
Flies: All flies tested were male Drosophila melanogaster, using TH-GAL4 (kind 
gift of Serge Birman) to manipulate dopaminergic neurons or nSyb-Gal4 (from 
Julie Simpson (corresponding Bloomington stock 51635) for pan-neuronal 
expression. Gr5a-LexA was used to express the LexOp-ReachR 
channelrhodopsin in the sugar sensitive neurons independently from the 
GAL4-UAS manipulations. Flies were raised and crossed using standard 
Drosophila protocols [9]. The full list of fly lines is in Table S1. 
To investigate a role for Rab10 in dopaminergic neurons, downstream of 
activated LRRK2, we recombined the TH-GAL4 with UAS-G2019S and 
designated these ‘PD-mimic’ flies as THG2. 
Western Blots: The levels of Rab10 and LRRK2-G2019S were assayed by 
Western Blot using standard protocols [9,14]. Primary antibodies were as 
follows: a-pan-Rab10 (Nanotools, clone 605B11), a-phospho-Rab10 (Abcam, 
ab230261, 1:1000), and for LRRK2 (Neuromab, clone N241A/34). We used  a-
synaptotagmin 91  as a loading control [21]. Selectivity of Rab10 antibodies 
was confirmed by using a rat CNS extract [9]. YFP-Rab10 was assayed as 
described recently [9], except that sample preparation included boiling. This  
uncouples the YFP from  Rab10, so that the MW was ~25 kDa (Fig. 1), 
whereas unboiled samples run at ~50 kDa [9]. Quantification of the blots was 
carried out in Fiji. 
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Bradykinesia was assessed using an optogenetic stimulus. Flies were fed 
retinal (1 mM) pipetted onto the surface of their food for 1 week in the dark at 
29 °C. They were restrained at 25 °C for 3 hours before the proboscis 
extension responses were observed with a Grasshopper 3 (Point Grey) camera 
mounted on a Zeiss Stemi microscope at 200 frames/second. A single flash 
was delivered from a ThorM470L3 LED, driven at 8 V for 7 ms. The stimulus 
was transcoded by LexOp-ReachR expressed in the Gr5a neurons. The area of 
the video occupied by the proboscis was automatically analysed by python 
code https://github.com/biol75/PER, and graphed in Excel. Only those flies 
which showed smooth extension (Fig. 2 aiv) or smooth extension and 
relaxation (Fig. 2 aiii), with no erratic movements were used for full analysis. 
The Tukey - post-hoc test was applied in R. 
Akinesia was recorded from 1 week old flies, kept in the dark at 29 °C. Flies 
were restrained as described [14] and starved at 29 °C for 3 hours before being 
offered a droplet of 100 mM sucrose three times. Each response was scored 
Yes/No and the median response for each fly used. The c2-post-hoc test 
(Fifer) was done in R (3.3.3). Standard errors were estimated from the 95% 
confidence intervals generated by the Binomial prediction. 
Visual assays: On the day of emergence, flies were placed in the dark or in 
disco-chambers at 29 °C. 1 week old flies were prepared for SSVEP (Steady 
State Visual Evoked Potential) measurements as recently described [9]. 
Stimuli were generated and responses recorded by an Arduino Due system 
with FFTs and contrast sensitivity computed in Matlab. Dunnett’s post-hoc 
test was applied in R. Full code at https://github.com/wadelab/flyCode. 
DPP (Deep-Pseudo-Pupil) images were captured with a Dino-Lite Camera 
and software, and images cropped, quantified and converted to grey scale in 
Fiji. Both images in Fig. 3a ii were combined in Fiji before the colour was 
removed and the contrast increased.  
Circadian rhythms and sleep patterns were recorded as described recently 
[22] with a TriKinetics DAM system. Flies were placed in the monitor at 29 °C 
on the day of eclosion, and locomotor activity was recorded in 1 minute bins 
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for 3 days under 12:12 h light/dark cycles followed by 7 to 10 days in constant 
darkness. Activity data was analysed using the ActogramJ plugin for ImageJ 
and sleep data using the ShinyR-DAM code [23] using the branch at 
https://karolcichewicz.shinyapps.io/ShinyR-DAM_3_1_Beta/. 
Conditioned courtship memory was recorded using the well-developed 
conditioned courtship memory protocol for Drosophila [24,25]. One-week old 
males, (kept at 29 °C), were provided with a virgin female and the time spent 
in courting behaviours measured. Half of the males had recently (~ 30 
minutes before) spent an hour with a mated female; half were naïve. Males 
who fail to ‘remember’ their rejection will spend more time courting the 
virgin female than controls. The Courtship Index (CI) was calculated as the 
percentage of ten minutes that a male spent courting; and the memory index 
(MI) by dividing the CI of each test fly by the mean CI of the naïve/sham flies 
of the same genotype.  A score of 0 indicates highest memory performance 
possible and a score of ≥1 indicates no memory. The distribution of MI was 
compared between genotypes using the Kolmogorov-Smirnov test. All naïve 
and trained groups contained 16-23 flies.   
Immunocytochemistry was performed on 3-5 day old flies expressing G2019S 
as described recently [14], using the LRRK2 mouse antibody (Neuromab, 
clone N241A/34).  In some flies, mCD8-GFP was also expressed in the 
dopaminergic neurons. Each figure is representative of three preparations 
from at least two crosses. 
Analysis of gene expression in the fly optic lobe. We interrogated the 
dataset generated by Davis et al [10] for the cell types in the opticlobe which 
express Rab10 and its potential interactors, using the tool which they 
provided at http://www.opticlobe.com . 
Results 
Validation of Rab10 knock-down and its phosphorylation by G2019S:  
We used three strategies for Rab10 reduction. (i) We used a CRISPR/Cas9-
generated Rab10 null [26], in which Rab10 was severely reduced: both pan-
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Rab10  and  phospho-Rab10 to less than 5% of wild-type (Fig. 1a,b). This line 
was not used in the visual assay because it carries a retinal RFP marker, which 
causes the eyes to fluoresce and this would distort the disco-chamber data. (ii) 
We used Rab10RNAi. This almost completely depleted phosphoRab10 (Fig. 1b), 
but a small amount (~15%) of Rab10 was still present (Fig. 1a). (iii) We used 
the deGradFP technique to knockout YFP-Rab10 protein with the vhhGFP 
nanobody, to target YFP-Rab10 to the proteasome.  This was used in flies in 
which the wild-type Rab10 had been replaced by homologous recombination 
so that the YFP-Rab10 was expressed at wild-type levels.  This reduced the 
amount of phospho-Rab10 to ~50% of wild-type (Fig. 1c). In the GFP-Rab10 
background, expression of a RNAi against GFP depleted some phospho-
Rab10, but not as much as the nanobody, so we did not use this further.   
The ability of LRRK2-G2019S to phosphorylate Rab10 in vivo was confirmed 
(Fig. 1d), by comparing nSyb > LRRK2-G2019S with the kinase-dead (KD) 
form (LRRK2-G2019S-K1906M). In the nSyb > LRRK2-G2019S flies, the level of 
pRab10 was similar to the effect of pan-neuronal expression of Rab10, being 
twice that of the wildtype or nSyb outcross or the nSyb > KD preparation.  
In flies, the GAL4-UAS system (which we are deploying here) has proved a 
robust means of transgene expression. In several systems, it has been shown 
that adding extra UAS constructs does not dilute the phenotype produced by 
a particular transgene, e.g. [27]. We wanted to check if the level of LRRK2-
G2019S protein remains the same when other transgenes are expressed at the 
same time. We confirmed that expressing Rab10 RNAi or the vhhGFP nanobody 
did not affect the level of G2019S (Fig. 1 e,f). No band was seen in wild-type 
flies [14], or those in which no G2019S was expressed (Fig. 1 f).  
We also tested if the fly homolog of LRRK2, dLRRK, phosphorylated Rab10. 
For this we deployed a dLRRK loss of function mutant (dLRRK LOF) which 
contains a PiggyBac transposon, resulting in reduced protein expression [28]. 
The mutant has as much pan-Rab10 as the wild-type, but much less phospho-
Rab10 (Fig. 1 g,h). Here we note that in human and mouse, LRRK1 does not 
appear to phosphorylate Rab10. 
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A variety of physiological consequences of Rab10 knock-down in dopaminergic 
neurons expressing LRRK2-G2019S   
We compared the ‘PD-mimic’ THG2 flies, in which only the dopaminergic 
neurons express LRRK2-G2019S with controls and with Rab10 knock-down in 
four types of behavioral/physiological phenotypes: bradykinesia in the 
proboscis extension response, neural signalling in the retina, sleep patterns 
and conditioned courtship memory. These four systems are controlled by 
different clusters of dopaminergic neurons.  
Rab10 reduction rescues LRRK2-G2019S bradykinesia 
The major features of Parkinson’s are movement deficits (bradykinesia), 
slowing or loss of movement and tremor. We therefore begin our analysis 
with the movement of PD-mimic THG2 flies. The Proboscis Extension 
Response (PER), a reaching movement used by Dipteran flies to obtain food, 
is particularly amenable to analysis [29] (Fig. 2a i, Movie M1). When a fly 
walks across a surface and encounters a droplet of sugary solution, the 
sucrose-sensitive neurons on the legs are stimulated and this elicits a rapid 
extension of the proboscis. The PER is modulated by a single dopaminergic 
neuron, the Tyrosine Hydoxylase Ventral Unpaired Median (TH-VUM) 
neuron [30], which has a high level of Rab10 expression [9]. Expression of 
G2019S in this neuron results in movement deficits – akinesia (loss of the 
PER), slower response (bradykinesia) and tremor [14]. Further, the PER can be 
elicited using an optogenetic stimulus. In this paradigm, the sucrose-sensitive 
sensory neurons in the leg express a channelrhodopsin which is stimulated by 
a flash of light. Expression of a channelrhodopsin by the LexA/LexOp system 
in the sugar-sensitive ‘Gr5a’ neurons on the leg is independent of the 
expression of LRRK2-G2019S in the TH-VUM and other dopaminergic 
neurons by the GAL4-UAS system [31]. This precise control of the stimulus 
makes it possible to measure the time course of the reaching movement, and 
separates the activation of the stimulus from manipulations using the GAL4 
system in the dopaminergic neurons. 
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In our optogenetic setup, 60% of control flies respond to a single flash of light 
by smoothly extending their proboscis, whereas flies in which Tyrosine-
Hydroxylase GAL4 was used to express LRRK2-G2019S (THG2) only respond 
30% of the time, i.e. G2019S induces akinesia (Fig. 2a ii). Those THG2 flies that 
do respond, take ~100 ms longer to achieve maximum extension, showing 
bradykinesia (Fig. 2a iii, iv). Knock-down of Rab10 using Rab10RNAi co-
expressed with LRRK2-G2019S in the dopaminergic neurons, fully reverts 
both akinesia and the bradykinesia (Fig. 2a ii-iv).  
We next tested if Rab10 knock-down would also rescue the deficits induced 
by G2019S in response to the natural stimulus, a sugar solution. Just over two-
thirds of control flies respond to sucrose (70%, Fig. 2b i, green bars), whereas 
less than half of THG2 flies respond to sucrose (46 %, Fig. 2b i, magenta).  This 
deficit is fully rescued when Rab10RNAi is co-expressed with THG2 (THG2 > 
Rab10RNAi Fig. 2b i, yellow). Dopaminergic expression of Rab10RNAi alone has 
no effect on the proportion of flies that respond to the sucrose solution (TH > 
Rab10RNAi, Fig. 2b i, green). 
As RNAi may have off-target effects, we supplemented this with a nanobody-
mediated-protein knockdown technique, deGradFP [32,33]. In this, we 
deployed flies in which the wild-type Rab10 gene had been replaced by YFP-
Rab10 by homologous recombination. Then we expressed an anti-GFP 
nanobody (vhhGFP) to deplete YFP-Rab10 protein in just the dopaminergic 
neurons using TH-GAL4. In this experiment, YFP-Rab10 flies with both 
G2019S and vhhGFP expression (Fig. 2b ii, yellow bar) responded identically 
to wild-types, or YFP-Rab10 controls in which dopaminergic neurons 
expressed just vhhGFP (Fig. 2b ii, YFP-Rab10; TH > vhhGFP green bar). This 
indicates a full rescue of the THG2 induced akinesia. We confirmed that 
expressing G2019S and vhhGFP in flies with wild-type Rab10 still resulted in 
akinesia (Fig. 2b ii, magenta bar).  
While the Rab10 knockout is lethal in mammals [34], the fly Rab10 null 
(Rab10¯) is viable [26]. We therefore tested if a global removal of Rab10 would 
also ameliorate the akinesia deficit in the THG2 flies. In the Rab10¯ 
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background, the THG2 Proboscis Extension Response is fully rescued (Fig. 2b 
iii, orange), to the same level as wild-type controls (Fig. 2b i, green). In control 
experiments, the proportion of Rab10¯ flies that responded to sucrose was 
identical to wild-types; this was true for the homozygote stock and for an 
outcross to TH in males (Rab10 is on the X-chromosome)(Fig. 2b iii, pale 
green).  
Rab10 is known to be phosphorylated by LRRK2 in vitro [2] and in the fly,  in 
vivo (Fig. 1). Phosphorylation is likely to be part of the activation mechanisms 
of Rab10. If increasing phosphorylation of Rab10 is a key event in LRRK2-
G2019S driven dysfunction in dopaminergic neurons, we would expect 
dopaminergic expression of Rab10 to phenocopy that of G2019S. We found 
that 55% of such TH > Rab10 flies responded to sucrose, in an almost identical 
manner to the THG2 flies (Fig. 2b iv) with pronounced akinesia. No further 
increase in akinesia is seen when both G2019S and Rab10 are expressed at the 
same time.  
To confirm that akinesia was solely dependent on dopaminergic Rab10, we 
took the Rab10 null, and crossed it with flies expressing Rab10 in just the 
dopaminergic neurons. Such Rab10¯; TH > Rab10 flies have akinesia when 
compared with the Rab10¯ flies (Fig. 2b iii).  Similarly, the Rab10¯; THG2 > 
Rab10 show even less response.  
Thus, the G2019S-induced movement deficits in the PER are rescued by 
depleting Rab10 in the dopamine neurons either at the mRNA level using 
RNAi, or at the protein level using a nanobody, or with the global null. 
Increasing Rab10 in the dopaminergic neurons induces akinesia similar to the 
expression of LRRK2-G2019S.  
Dopaminergic reduction in Rab10 rescues G2019S-induced visual deficits  
People with Parkinson’s also show visual deficits including loss of 
dopaminergic neurons from the retina [35,36]. Aged THG2 flies also show 
strong retinal degeneration with vacuoles throughout the optic lobe [15]. To 
demonstrate retinal degeneration, we deployed the ‘Deep-Pseudo-Pupil’ 
(DPP) assay [37].  When wild-type flies are illuminated from below, they 
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show a DPP, with about  6-8 glowing ommatidia. In this, the normal retinal 
structure focuses light from directly below towards the observer through the 
center of the ommatidium, whereas light which is off-center is blocked by the 
pigment granules at the edge of the ommatidium (Fig. 3a i). We tested several 
types of genetic background for the THG2 ‘PD—mimic’ flies used in 
movement assays and found that the contrast between DPP and the red eye 
pigment was best when the THG2 was in the deGradFP background. 
Although the DPP was clear in these young flies, in flies aged for 14 days, the 
DPP is distorted in these THG2;vhhGFP flies (Fig. 3a ii-iv). The outline of the 
DPP is irregular, rather than a neat ellipse, and the number and dispersion of 
the glowing ommatidia was increased. However, when dopaminergic Rab10 
is depleted in the THG2 deGradFP fly, the DPP is much less disrupted (YFP-
Rab10; THG2 > vhhGFP Fig. 3a ii-iv). There are fewer light-transmitting 
ommatidia and they are all adjacent. Thus, dopaminergic Rab10 reduction is 
sufficient to rescue the G2019S-induced neurodegeneration. We conclude that 
expression of G2019S leads to degeneration of the retina, including disruption 
of the pigment granules and regular hexagonal patterning.  
In People with Parkinson’s, the retinal degeneration of dopaminergic 
amacrine cells is accompanied by changes in contrast detection e.g. [38].  We 
therefore tested if the anatomical degeneration of the fly eye is linked to a loss 
of visual physiological contrast sensitivity. To do this, we used the SSVEP 
(Steady State Visual Evoked Potential) method which is automated to 
distinguish the photoreceptor contrast sensitivity from the synaptic response 
of the second order lamina neurons. At 7 days, all dark-reared control and 
THG2 flies show a strong SSVEP photoreceptor signal, indicating that the eyes 
are functioning normally. There is no effect of the manipulation of Rab10 (Fig. 
3b, solid bars). On the other hand, when exposed to a mild visual stress to 
accelerate neurodegeneration (by being kept in the disco chamber for 1 week 
[15]), the THG2 flies lose almost all their visual response – it is reduced to 
18 % of the wild-type dark level (Fig. 3b ii,iii, hatched magenta bars; controls 
in green), indicating loss of photoreceptor function. As with the anatomical 
measure, the contrast sensitivity of the eye was rescued using the deGradFP 
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manipulation (YFP-Rab10; THG2 > vhhGFP, Fig. 3b ii, yellow bar). With co-
expression of Rab10RNAi, this THG2 deficit is also fully rescued (Fig. 3b iii, 
yellow bar).  
Thus, both electrophysiological response and structural observation of the 
DPP indicate that Rab10 knock-down rescues the effect of dopaminergic 
LRRK2-G2019S. 
LRRK2-induced daily activity deficits are not affected by Rab10 
A third behavior modulated by dopaminergic neurons is the daily sleep-wake 
rhythm, both in human [39] and fly [40] (see [41] for review).  The 
dopaminergic neurons that innervate the fly mushroom bodies are key 
players in the daily activity rhythm. Locomotor activity measured over 
several days provides a measure of circadian rhythm and sleep-wake 
behavior (Fig. 4a). Periods of inactivity longer than 5 minutes defined as 
‘sleep’ (see [42]). In 12h:12h light on:off cycles, all flies tested show a daily 
sleep-wake rhythm, sleeping more in the light than in the dark, with THG2 
flies sleeping ~15% more than the controls during the ‘day’ (Fig. 4b). At the 
light/dark transition, all flies have high, persistent activity, and little sleep. 
THG2 flies continue their activity during the dark, spending less than 50% of 
the time ‘asleep’ in the dark that control flies managed (TH/+, Fig. 4b). Neither 
reduction nor increased expression of Rab10 in dopaminergic neurons 
affected the sleep/wake cycle of either the control or LRRK2-G2019S flies. 
Following light-dark entrainment (LD), in the dark (DD), the fly locomotor 
activity pattern persists with a ~24 hour cycle providing a measure of intrinsic 
circadian rhythms. The period of the circadian rhythm was not affected by 
LRRK2-G2019S or Rab10 manipulation, though a small reduction was seen 
when both transgenes were expressed (Fig. 4a). This is not unexpected as the 
circadian period is not affected by dopamine manipulations [43].      
Thus, the normal sleep-wake cycle is disrupted by dopaminergic LRRK2-
G2019S, but not by Rab10 manipulation, even though Rab10 in the context of 
LRRK2-G2019S is seen to regulate the Proboscis Extension Response and 
retina.      
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Improved Memory due to Rab10 depletion is insensitive to LRRK2-G2019S 
Dopaminergic circuits also affect memory in both human [44] and fly [45,46]. 
We deployed the conditioned courtship short-term memory protocol, which 
is dependent on the well-known dopaminergic neurons that project to the 
mushroom bodies (MB) [47] to assess the effects of Rab10 and G2019S. In this 
assay, males are allowed to court mated females, which reject their advances. 
When presented with more receptive virgin females, they tend to court less as 
they ‘remember’ their rejection. We found that dopaminergic knock-down of 
Rab10 substantially reduced the memory index, with just over half of the TH 
> Rab10 RNAi flies having a memory index less than 0.05, i.e. they have 
excellent memory. In contrast, only 10% of control flies had a memory index 
less than 0.05 (Fig. 5). When G2019S was expressed, no change in the 
distributions was seen, and Rab10 depletion still improved memory (Fig. 5).      
We conclude that, in the conditioned courtship assay, Rab10 is present and 
has a key role in the dopaminergic neurons, but that the behavior is not 
affected by dopaminergic expression of G2019S.     
Cytoplasmic Location of G2019S and Rab10    
A variety of distributions for LRRK2 has been reported (microtubule [48], 
TGN [49], mitochondria [50], lysosome [51] or on synaptic vesicles [52]), but 
the location of LRRK2 has not, to our knowledge, been reported in fly 
neurons. In comparison, the fly ortholog, dLRRK, is focused at the Golgi-
membranes [28]. We therefore tested where ectopically expressed LRRK2-
G2019S protein is detected in dopaminergic neurons. Staining was seen more 
strongly in the cytoplasm than in the nucleus (Fig. 6a). Additionally, there is 
weak staining along the axons and of the synaptic endings, including the 
mushroom bodies and fan-shaped body (Fig. 6b). A similar pattern of staining 
is seen with dopaminergic expression of hLRRK2-wild-type (data not shown). 
Rab 10 expression (TH > Rab10-YFP flies, Fig. 6c) shows a staining in the 
cytoplasm, with the strongest fluorescence at the synaptic terminals, 
noticeably in the neuropil of the mushroom bodies and fan-shaped body. The 
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similar distribution allows for plenty of interaction sites, which would be 
necessary for phosphorylation. 
Expression of Rab10 and its potential interactors in PAM neurons 
The gene expression pattern in the opticlobe and in three types of 
dopaminergic PAM neurons was determined by Davis et al (2020) [10]. We 
interrogated this dataset to examine the expression of a Rab10 GEF, two GAPs 
and three effectors (Table 1). While two of the Rab10 effectors (Ehbp1 and Rilpl 
(CG11448)) are expressed in every cell type, the other genes are not 
universally recorded. In fact, the neurons in which the genes are expressed 
differ substantially. This is indicated by analysis of the PAM neurons: PAM1 
and PAM3 omit Crag and Mical, whereas PAM4 does not express plx or Mical. 
We also note that dLRRK is not expressed in the PAM neurons. 
Discussion 
Having previously demonstrated a strong genetic interaction, in vivo, between 
LRRK2 and Rab10 [9], we sought to determine whether manipulation of 
Rab10 affected the physiological deficits associated with flies expressing 
LRRK2 G2019S. We have identified a requirement for Rab10 in mediating the 
movement and visual deficits induced by dopaminergic expression of LRRK2-
G2019S. In contrast, in two other dopaminergic physiological systems, there 
was no interaction: in one (the circadian sleep/wake cycle) LRRK2-G2019S 
has a marked phenotype independent of Rab10; in the other (conditioned 
courtship memory) Rab10 has a distinct role, but there is no LRRK2-G2019S 
phenotype. As such, we have begun to identify the individual dopaminergic 
circuits in the fly that are most sensitive to LRRK2-Rab10 interplay (Fig. 7).  
Rab10 knock-down rescues movement and visual deficits from dopaminergic LRRK2-
G2019S expression 
Movement and visual deficits induced by LRRK2-G2019S expression have 
been linked to low dopamine release in the TH-VUM and some PPL/MC  
neurons that control the PER and vision respectively [14,15]. We focus here on 
how the LRRK2-Rab10 interaction might lead to a potential loss of dopamine 
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release. First, Rab10 is strongly expressed in these neurons [9] and so could 
play a role in controlling dopamine traffic or exocytosis.  LRRK2-G2019S 
expression in the fly CNS increases the phosphorylation of Rab10 
approximately two-fold.  Knock-down by Rab10RNAi reduces the level of 
pRab10 below the level at which it is detected, though some Rab10 is still 
present. Additionally, protein knock-down using deGradFP lowers pRab10 
and rescues the proboscis extension/visual deficits, though the reduction in 
Rab10 reported by Western Blot was not so strong as with Rab10RNAi. Thus, 
the amelioration, in vivo of G2019S-induced movement and visual deficits by 
Rab10RNAi is in accord with data from cell culture that Rab10 is a key target of 
LRRK2 [2–7].  Our data additionally shows, at least for a subset of Drosophila 
dopaminergic neurons, Rab10 is likely a relevant physiological substrate for 
LRRK2-G2019S.  
This genetic interaction between Rab10 and LRRK2-G2019S does not imply 
that the physical interaction is direct, though the anatomical evidence shows 
that both proteins spread along the axons to the synaptic endings and are 
likely in proximity. Rab proteins often work in functionally linked chains – for 
example Rab29 and Rab10 both interact with LRRK2. [53,54]. Our data does 
not exclude that the LRRK2-G2019S deficits also involve other Rabs.  
The cellular consequences of phosphorylation of Rab10 are not yet fully clear, 
but it has been suggested that this may switch the effectors to which Rab10 
binds [8,54,55].   In dividing cells in culture phosphorylation of Rab10 by 
LRRK2 reduces ciliogenesis [56,57].  However, the relevance of this to the 
terminally differentiated adult Drosophila CNS neurons is not clear.  Both 
LRRK2 and Rab10 have been linked to mitochondrial damage resolution, 
through the Rab10 effector OPTN (optineurin) [50] though  Drosophila do not 
have an evident OPTN homolog (this function could be fulfilled by an as yet 
unidentified protein). Another role for LRRK2 – control of vesicle transport at 
the TGN – has support from HEK cells  [49] and fly neurons. In the fly retina, 
a Rab10 interaction has been reported occurring at the TGN with its GEF Crag 
and effector Ehbp1 [58], affecting vesicle budding. Interestingly, the fly 
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ortholog of LRRK2, which is dLRRK, is linked to the golgin protein, Lava 
lamp, at Golgi outposts in neurites [28]. An effect on vesicle transport at the 
TGN, along with consequent endosomal disruption [51,53,59,60] may provide 
an explanation for a lack of dopamine release.   
Sleep/wake cycles and conditioned courtship memory do not depend on an interaction 
between Rab10 and LRRK2-G2019S 
In stark contrast, in the same animals, dysfunction in other dopamine- 
mediated behaviours does not require Rab10. Rab10RNAi did not ameliorate the 
change in daily sleep defect induced by LRRK2-G2019S, and overexpression 
of Rab10 did not phenocopy G2019S- induced sleep defects.  While Rab10RNAi 
expression affected the conditioned courtship memory, indicating the 
presence of Rab10 and its importance in these dopaminergic neurons, LRRK2-
G2019S had no phenotype. Thus, Rab10 seems to be present, but not affected 
by LRRK2-G2019S.    
Dopaminergic neurons  display varied levels of Rab10 even within a 
particular cluster [9]. Consequently, it is possible that the Rab10 GEFs, GAPs 
and effectors may also differ between the subsets of the dopaminergic  
neurons in the PAM, PPL1 and PPM3 neurons, the clusters that regulate the 
sleep-wake cycle [40,61,62] – indeed the three types of PAM neurons express a 
different subset of Rab10 interactors.  Further, dLRRK is expressed in the 
dopaminergic neurons in the optic lobe, but not in the PAM neurons. The 
variation in gene expression may explain why some labs have identified other 
potential LRRK2 interactors – for example EndophilinA, in Drosophila larval 
glutamatergic neuromuscular synapses [63].  
Conclusion: Our key finding is that that LRRK2-G2019S may signal by 
several pathways, even within the dopaminergic neuron population.  We 
conclude that an uneven distribution of Rabs, their effectors and binding 
partners may contribute to the differences in the rate of dopaminergic neuron 
degeneration in the human striatum. Multiple LRRK2 pathways may also 
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 Table of Abbreviations 
Abbreviation Full text 
CI Courtship Index 
DAM Drosophila activity monitor  
dLRRK The Drosophila homolog of LRRK2 
DPP Deep-Pseudo-Pupil 
FFT Fast-Fourier Transform  
Gal4/UAS  A binary system for targeted gene expression in the 
fly 
GAP GTPase-activating protein 
GEF Guanine nucleotide exchange factor 
LED Light-Emitting Diode 
LexA/LexOp A second, independent binary system for targeted 
gene expression in the fly 
LRRK2 Leucine-rich-repeat kinase2 
MC dopaminergic neurons in the optic lobe (also known 
as Mi15 neurons)  
MI Memory index 
nSyb neuronal Synaptobrevin 
OPTN  optineurin 
PAM A cluster of dopaminergic neurons in the fly brain 
PER Proboscis Extension Response 
PPL A second cluster of dopaminergic neurons in the fly 
brain  
PPM Another cluster of dopaminergic neurons in the fly 
brain 
SSVEP Steady State Visual Evoked Potential 
TGN Trans-Golgi Network 
TH Tyrosine-Hydroxylase  
TH-VUM Tyrosine Hydoxylase Ventral Unpaired Median 
neuron 
THG2 Flies with TH Gal4 recombined with UAS-LRRK2-
G2019S (PD-mimic) 
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Fig. 1. Validation of Rab10 depletion and phosphorylation in vivo.    a) A 
pan-hRab10 antibody detects dRab10 and shows that Rab10 is increased by 
neuronal (nSyb-GAL4) expression of UAS-Rab10, abolished in the Rab10¯ null, 
and substantially reduced by neuronal expression of Rab10RNAi. Antibody-
specificity was confirmed by rat CNS binding. b) A phosopho-hRab10 
antibody detects phospho-dRab10, which is increased by neuronal expression 
of UAS-Rab10, but undetectable with the Rab10¯ null or with neuronal 
expression of Rab10RNAi. c) Validation of deGradFP technique. In flies where 
endogenous Rab10 has been replaced by YFP-Rab10, global (Act5c-GAL4) or 
neuronal expression of the vhhGFP nanobody reduces the level of YFP-Rab10 
by ~50%. A slightly smaller reduction is achieved by neuronal expression of 
GFPRNAi. d) Neuronal expression of Rab10 increases pRab10, as does neuronal 
expression of LRRK2-G2019S. Neuronal expression of a kinase-dead LRRK2 
(KD, LRRK2-G2019S-K1906M) has no effect on the phosphorylation of Rab10. 
e) Adding Rab10 RNAi expression does not reduce the level of LRRK2-
G2019S.  f) Adding expression of the GFP nanobody does not reduce the level 
of LRRK2-G2019S. Note that the THG2 and TH > G2019S samples in f are 
different to those in e. g) The fly LRRK2 ortholog, dLRRK has a severe loss of 
function P-element insertion. This mutant reduces the phosphorylation of 
Rab10.  h) dLRRK, however, does not affect the pan-Rab10 level. Loading 
control: α-drosophila-synaptotagmin (α-syt), which recognizes at least 3 
isoforms, depending on the blot time. Each panel contains a sample blot and 
quantification (using the upper α-syt band for each blot) below. Exact 
genotypes and in Table S2. 
Fig. 2. Rab10 knock-down rescues LRRK2-G2019S -induced bradykinesia.  
a) Optogenetic stimulation of the Proboscis Extension Response (PER). ai) 
To reach for food or liquid, the fly extends its proboscis in response to an 
optogenetic stimulus to sensory neurons on the legs. The full extension 
response is shown in Movie M1. aii) Expression of LRRK2-G2019S in 
dopaminergic neurons (THG2) reduces the proportion of flies that respond to 
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a single flash of light, and this is rescued by Rab10 reduction with Rab10RNAi. 
aiii. Dopaminergic reduction of Rab10 rescues the bradykinesia (slower 
response) of flies expressing G2019S in their dopaminergic neurons. aiii). Raw 
traces; aiv). Mean data. To respond to the optogenetic stimuli all flies carry 
LexA/Op Gr5a>ReachR. b) Sucrose stimulation of the PER. bi) Flies expressing 
G2019S in their dopaminergic neurons (THG2, magenta bars) respond less 
frequently to sucrose than wild-type flies (green) i.e. they show akinesia. This 
is rescued in THG2 flies with dopaminergic reduction in Rab10 using 
Rab10RNAi (THG2 > Rab10RNAi). bii) Reduction of dopaminergic Rab10 with the 
deGradFP technique (Rab10 YFP; THG2>vhhGFP, yellow bars) also rescues the 
G2019S-induced akinesia. biii) The Rab10 null (Rab10¯, orange bar) also 
reverts the G2019S deficit, while expression of Rab10 in the null background 
again induces akinesia (Rab10¯; TH > Rab10, light blue bar). biv) By itself, 
Rab10 overexpression phenocopies G2019S expression. Exact genotypes and 
full statistical data in Table S3. 
Fig. 3. Visual degeneration due to LRRK2-G2019S is rescued by 
dopaminergic knock-down of Rab10. a) Anatomically, dopaminergic Rab10 
knock-down rescues the loss of eye structure. ai) Healthy flies have a 
marked DPP (Deep-Pseudo-Pupil) which can be seen when the eye is 
illuminated from underneath. Light passing directly though the eye is focused 
towards the observer, but light at an angle is blocked by the pigmentation in 
the ommatidia. aii-aiv). PD-mimic flies (THG2; vhhGFP) kept in the dark for 
14 days lose their focused DPP as the eyes show an increased number of 
ommatidia transmitting light, spread over a wider area, with the loss of 
pigmentation indicating lysosomal dysfunction. Much less degeneration is 
seen when Rab10 is depleted using the deGradFP technique (YFP-Rab10; 
THG2; vhhGFP flies). b). Physiologically, dopaminergic Rab10 knock-down 
rescues neuronal vision. bi) Degeneration is accelerated by a mild visual 
stress achieved by keeping the flies in ‘disco-chambers’ where the light is 
turned on and off approximately every 2 seconds; these flies were compared 
with those kept in the dark. bii-iii). Flies kept in the dark have normal visual 
responses after 7 days. However, THG2 flies in disco chambers lose their 
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physiological response after 7 days (hatched magenta bar, controls in green). 
This is rescued by deGradFP mediated knockdown of Rab10 protein (bi, 
Rab10 GFP; THG2; vhhGFP hatched yellow bar) or by dopaminergic knock-
down of Rab10 by RNAi (biii, THG2 > Rab10RNAi yellow bar). biv) By itself, 
Rab10 overexpression has no effect. Exact genotypes and statistical data in 
Table S4. 
Fig 4. Rab10 knock-down does not rescue sleep deficits induced by 
dopaminergic expression of LRRK2-G2019S. A. There is no effect of LRRK2-
G2019S or Rab10 expression on circadian period in continuous darkness (DD), 
and only a small reduction in circadian period when both genes are 
expressed. ai) Raw actograms; aii) mean period from days 6-9 in DD. Our 
control flies, in which no transgene was expressed is TH/+. b) In Light/dark 
(LD), THG2 flies show increased sleep during the day, and reduced sleep at 
night. Neither reduced nor increased expression of Rab10 affects the daily 
pattern of sleep (bi), with summary data in bii. Sleep is defined as periods of 
inactivity longer than 5 min. Exact genotypes and statistical results in Table 
S5. 
Fig. 5. Memory depends on dopaminergic Rab10 but not LRRK2-G2019S.  A. 
Depletion of Rab10 in the control background (TH > Rab10RNAi) increases the 
proportion of flies with low memory index (MI) compared to flies with no 
transgene expression (TH/+). Expression of LRRK2-G2019S has no effect on 
performance; either for the THG2/+ v TH/+ control flies, nor for the flies with 
Rab10RNAi. a) Raw scores, b) summary data. Exact genotypes and statistical 
results in Table S6. 
Fig. 6. LRRK2-G2019S is found in the cytoplasm of the cell soma and in the 
synaptic endings of dopaminergic neurons. a) Confocal stack through the 
TH-VUM and DADN neurons in the ventral part of the brain of a THG2 > 
mCD8-GFP fly. Note that LRRK2 protein is found more in the cytoplasm than 
the nucleus, and that there are areas of the cytoplasm with less LRRK2 
staining. mCD8-GFP expression is used to mark dopaminergic neurons. The 
confocal stack spans the whole depth of these dopaminergic neurons.  b) 
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LRRK2 is found in the synaptic endings in the mushroom bodies (MB) and 
weakly in the fan-shaped body (FB). Single confocal section with a-LRRK2 
antibody, cropped to select the neuropil. c) Dopaminergically expressed 
Rab10-YFP is found in the same synaptic neuropils. Stack of two confocal 
images, cropped to include just the neuropil. Images representative of at least 
3 preparations. Exact genotypes in Table S7. 
Fig. 7. Multiple pathways of LRRK2-G2019S / Rab10 interaction in 
dopaminergic neurons. Rab10 depletion ameliorates the proboscis extension 
bradykinesia and loss of synaptic signalling in the retina induced by LRRK2-
G2019S expression (magenta arrows/orange crosses). Rab10 manipulation 
does not affect the ‘sleep’ phenotype from LRRK2-G2019S (magenta arrow). 
Reduction of Rab10 facilitates conditioned courtship memory, but LRRK2 has 
no effect (yellow arrow). All manipulations of Rab10 and G2019S in 
dopaminergic neurons, shown in the outline of the brain (filled cells have 
high levels of Rab10 [9]). We conclude that Rab10 and LRRK2 interact in 
some, but not all dopaminergic neurons. This may underlie differences in the 
susceptibility of different human striatal dopaminergic cells to Parkinson’s 
and explain why differences in the age at which  symptoms are first noted.   
 
Movie M1. Extension of the proboscis in response to an optogenetic 
stimulus. A flash of blue light is used to excite the GR5a sugar-sensitive 
neurons which leads to the extension of the proboscis. The outline of the fly 
(red line) was determined by thresholding. The distance between the fixed 
reference point and the lowest point of the proboscis (cyan dots) was 
measured automatically on each frame. Each frame is 6 ms. Exact genotype: 
Gr5a::ReachR / + ; +/+. 
 







































































































































































































































































































































































































































































































































































































































   
   
   















































































































































































































   
   
   

































Gr5a > ReachR, N=13
Gr5a::ReachR / +, N=38
Gr5a::ReachR / THG2, N=21
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